Patents Examined by Bradley L. Sisson
  • Patent number: 11939629
    Abstract: The current document relates generally to the field of nucleic-acid detection and, in particular, to a highly sensitive and specific nucleic-acid-detection method that includes hybridization of a specific nucleic-acid target to a recognition probe, subsequent specific cleavage of the double-stranded target-probe helix at a specific restriction site, and exponential amplification of the enzymatic cleavage accompanied by release of a molecular marker.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: March 26, 2024
    Inventor: Andrei Gindilis
  • Patent number: 11879152
    Abstract: This invention describes a method of controlling the hybridization yield of nucleic acid probes by adjusting the relative concentrations of auxiliary oligonucleotides to the probes and the targets. The auxiliary oligonucleotide is partially or fully complementary to either the probe or the target, and is released upon hybridization of the probe to the target.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: January 23, 2024
    Assignee: William Marsh Rice University
    Inventors: David Yu Zhang, Ruojia Wu, Juexiao Wang
  • Patent number: 11866769
    Abstract: Subject of the present invention is a combination of nucleic acid molecules capable of hybridizing with a target nucleic acid sequence. In order to overcome problems with the reproducibility of FISH assays and to decrease assay time, hairpin probes are used in combination with helper probes annealing adjacent to the target site of the hairpin probe.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: January 9, 2024
    Assignee: MIACOM DIAGNOSTICS GMBH
    Inventors: Ian Peter Thrippleton, Walter Freiherr Von Stein
  • Patent number: 11851646
    Abstract: A solution for extracting substantially pure RNA from a biological sample is disclosed. The solution for extracting RNA from a biological sample containing RNA and at least DNA comprises: (a) phenol in an amount of more than 50% by volume based on the total amount of the solution; (b) a polyol in an amount of 3 to 10% by volume based on the total amount of the solution; (c) a guanidinium salt at a concentration of 0.5 to 2.0 M based on the total amount of the solution; (d) a thiocyanate at a concentration of 0.1 to 0.5 M based on the total amount of the solution; and (e) a buffer for maintaining the pH of the solution at 4 to 6.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: December 26, 2023
    Assignee: Toray Industries, Inc.
    Inventors: Makiko Yoshimoto, Hideo Akiyama, Hitoshi Nobumasa
  • Patent number: 11821034
    Abstract: Provided are methods of nucleic acid sample preparation for analysis, including analysis using nanopore sequencing applications. In particular provided are methods that allow for the creation of circular and linear DNA samples that contain asymmetric ends to ligate different and desired adaptors to the end of the sample, methods to create single nucleic acid molecules that automatically form concatemers for higher sequencing throughput; methods to create multiple copies (temperature dependent, multi-primed, open-fold replication) of one original nucleic acid sample, or to create single nucleic acid molecules containing multiple copies of more than one original nucleic acid sample (concatemerized samples) for improved accuracy and throughput are described; and methods for improved modified base calling.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: November 21, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Randall Davis, Michael Dorwart, Janine Mok
  • Patent number: 11761029
    Abstract: Described herein are devices, systems, fluidic devices, kits, and methods for detection of target nucleic acids associated with diseases, cancers, genetic disorders, a genotype, a phenotype, or ancestral origin. The devices, systems, fluidic devices, kits, and methods may comprise reagents of a guide nucleic acid targeting a target nucleic acid, a programmable nuclease, and a single stranded detector nucleic acid with a detection moiety. The target nucleic acid of interest may be indicative of a disease, and the disease may be communicable diseases, or of a cancer or genetic disorder. The target nucleic acid of interest may be indicative of a genotype, a phenotype, or ancestral origin.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: September 19, 2023
    Assignee: MAMMOTH BIOSCIENCES, INC.
    Inventors: Janice Sha Chen, Ashley Tehranchi, Andrew Besancon Lane, James Paul Broughton, Lucas Benjamin Harrington, Maria-Nefeli Tsaloglou, Xin Miao, Clare Louise Fasching, Jasmeet Singh, Pedro Patrick Draper Galarza
  • Patent number: 11739371
    Abstract: The invention relates to methods of detecting a genetic variation in a genetic sample from a subject using labeled probes and counting the number of labels in the probes. The invention also relates to manufacturing and using molecular arrays and analytical approaches based on single molecule detection techniques.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: August 29, 2023
    Assignee: Invitae Corporation
    Inventors: Patrick James Collins, Adrian Nielsen Fehr, Jill Lyndon Herschleb, Hywel Bowden Jones
  • Patent number: 11725230
    Abstract: The present disclosure provides methods for preparing a target mutant nucleic acid for subsequent enrichment relative to a wild type nucleic acid using nucleases that have a substantially higher activity on double stranded DNA versus single stranded DNA or RNA. The present disclosure also includes methods for enriching a target mutant nucleic acid and for preparing unmethylated/methylated nucleic acids of interest for subsequent enrichment.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: August 15, 2023
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Gerassimos Makrigiorgos, Chen Song
  • Patent number: 11702702
    Abstract: Disclosed are systems and methods for detecting genetic alterations comprising androgen receptor gene splice variants (AR-Vs), mutations, indel, copy number changes, fusion and combination thereof, in a biofluid sample from the patient. The systems and methods are similarly applicable to the detection of gene alterations comprising gene splicing variants, mutations, indel, copy number changes, fusion and combination thereof of other genes of interest. The streamlined methods improve the consistency and simplicity of non-invasive detections of biomarkers.
    Type: Grant
    Filed: April 16, 2017
    Date of Patent: July 18, 2023
    Assignee: Predicine, Inc.
    Inventors: Shidong Jia, Pan Du, Xiaohong Wang
  • Patent number: 11685915
    Abstract: A method utilizes an aluminum oxide support with a water-soluble neutral polymer adsorbed on a surface of the aluminum oxide support and is aimed to collect nucleic acids from a body fluid sample. The method includes a step of adsorbing nucleic acids on the support in the presence of a chaotropic agent and a step of adding a solution containing an anionic surfactant to the nucleic acid-adsorbed support.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: June 27, 2023
    Assignee: Toray Industries, Inc.
    Inventors: Shota Sekiguchi, Taiga Arai, Masateru Itou
  • Patent number: 11685922
    Abstract: The invention relates to a new method of determining in a sample the presence or absence of one or more analyte members of a group of two or more analytes. The invention therefore relates to a multiplex assay for determining the presence or absence of each analyte in a group of multiple analytes. The assay uses aptamers and transmembrane pores.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: June 27, 2023
    Assignee: Oxford Nanopore Technologies PLC
    Inventors: Daniel John Turner, Daniel George Fordham, Roger Charles Gill, Clive Gavin Brown, Stuart Reid, James Anthony Clarke, James White
  • Patent number: 11634769
    Abstract: A method of determining one or more target nucleic acids in cells includes the steps of: delivering one or more probes into the cells, each of the one or more probes being capable of binding with corresponding target nucleic acid present in the cells to form a double-stranded sequence; inserting an array of functionalized nanoneedles into the cells to bind with the double-stranded sequence; and hybridizing the bound double-stranded sequence with a first and second DNA sequence to produce a hybridized product, the first and second DNA sequence being at least partially complementary to each other. A kit for determining a target nucleic acid in cells includes a first reagent comprising a probe for binding with the target nucleic acid to form a double-stranded sequence; and an array of functionalized nanoneedles comprising a protein for binding with the double-stranded sequence.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 25, 2023
    Assignee: City University of Hong Kong
    Inventors: Peng Shi, Zixun Wang, Wenjun Zhang, Linfeng Huang, Xin Wang
  • Patent number: 11603555
    Abstract: In various embodiments methods of determining methylation of DNA are provided.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: March 14, 2023
    Assignee: CEPHEID
    Inventors: Edwin W. Lai, Andrew Kohlway, Reuel Vanatta, Russell Higuchi, Alexander Gall, Kriszten Kocmond
  • Patent number: 11573235
    Abstract: A method for generating an image of a region of interest in a biological sample comprising the steps of: generating a first image including the region of interest of the biological sample having undergone a first protocol but not a second protocol; and generating a second image including the region of interest of the biological sample after having undergone a second protocol; wherein the region of interest is smaller than said sample. Also provided is a method of analyzing a biological sample, comprising providing an image of the biological sample according to the method for generating an image of a region of interest in a biological sample, and analyzing the biological sample from the image. Further provided are system and kit that comprise the means for executing the novel methods.
    Type: Grant
    Filed: March 21, 2013
    Date of Patent: February 7, 2023
    Assignee: LEICA MICROSYSTEMS CMS GMBH
    Inventors: Antti E. Seppo, Fiona Ginty, Kevin B. Kenny, David Lavan Henderson, Michael J. Gerdes, Adriana Ines Larriera, Xiaofeng Liu, Alex D. Corwin, Stephen E. Zingelewicz, Thomas Ha, Natalia R. Jun, Ainura Kyshtoobayeva, Denise A. Hollman-Hewgley, Ying Li
  • Patent number: 11542494
    Abstract: The present invention pertains to a method for isolating a target nucleic acid including small target nucleic acids from a sample, said method comprising at least the following steps a) binding at least a portion of the target nucleic acid including small target nucleic acids to a nucleic acid binding solid phase comprised in a column by passing the sample through said column, b) performing an enzymatic and/or chemical treatment on the nucleic acid binding solid phase while the target nucleic acid is bound to said solid phase, c) collecting at least a portion of the small target nucleic acids released from the solid phase during said treatment of step b) as flow-through, d) contacting said flow-through which comprises small target nucleic acids mixed with a recovery solution with a nucleic acid binding solid phase for binding the contained small target nucleic acids to said nucleic acid binding solid phase, e) optionally performing an elution.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: January 3, 2023
    Assignee: QIAGEN GmbH
    Inventors: Vera Holländer, Gabriele Christoffel, Martin Schlumpberger
  • Patent number: 11519026
    Abstract: Sequencing adaptors and methods are provided for preparation of polynucleotides for sequencing. The sequencing adaptors contain a portion of a recognition sequence for a methyl-dependent endonuclease. Unwanted adaptor dimers that form during ligation of adaptors to target polynucleotides produce a complete restriction sequence and are cleaved by the endonuclease, followed by exonuclease digestion, thereby removing the dimers.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: December 6, 2022
    Assignee: Roche Sequencing Solutions, inc.
    Inventors: Arkadiusz Bibillo, Randall W. Davis
  • Patent number: 11512343
    Abstract: The present invention provides an oligonucleotide probe for single nucleotide polymorphism detection to be used for a target nucleic acid where a single nucleotide polymorphism is present, the oligonucleotide probe comprising a reporter region, an anchor region, and a linker region. The reporter region comprises: an oligonucleotide consisting of a sequence perfectly matching when a nucleotide of the single nucleotide polymorphism is a first nucleotide, and mismatching when the nucleotide of the single nucleotide polymorphism is a nucleotide other than the first nucleotide; and a fluorescent dye quenching when the reporter region hybridize to the target nucleic acid.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: November 29, 2022
    Assignee: Eiken Kagaku Kabushiki Kaisha
    Inventor: Satoru Michiyuki
  • Patent number: 11499178
    Abstract: Provided is a labeling method for nucleic acid including a reaction step for hybridizing a nucleic acid probe that has a nucleotide sequence complementary to that of a nucleic acid to be labeled and contains a reactive nucleobase derivative incorporated at a position complementary to that of a target nucleobase as a target of labeling in the nucleic acid to be labeled, to the nucleic acid to be labeled; a transferring step for transferring a transfer group contained in the reactive nucleobase derivative to the nucleotide residue containing the target nucleobase in the nucleic acid to be labeled; and a labeling step for labeling the transfer group transferred to the nucleotide residue with a radioactive material.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: November 15, 2022
    Assignees: Kyushu University, National University Corporation, Kurume Research Park Co., Ltd.
    Inventors: Shigeki Sasaki, Yosuke Taniguchi, Gakuro Harada
  • Patent number: 11447814
    Abstract: The present invention relates to the detection of a target nucleic acid sequence from a DNA or a mixture of nucleic acids by a PCE-hCTO (PTO Cleavage and Extension using hCTO) assay on a solid phase. According to the present invention, the extended duplex is formed in a liquid phase in a target-dependent manner and then its presence is detected on a solid phase. Since hCTO is not immobilized onto a solid phase, the extended duplex is more effectively formed in a liquid phase.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: September 20, 2022
    Assignee: SEEGENE, INC.
    Inventors: Jong Yoon Chun, Young Jo Lee
  • Patent number: 11434533
    Abstract: Disclosed herein is a nucleic acid probe for detecting a target nucleic acid. At least one terminal of the probe-binding region in the target nucleic acid is a guanine base, and one or more cytosine bases are present within 1 to 7 bases from the guanine base. The nucleic acid probe comprises an oligonucleotide having a cytosine base facing the guanine base on a terminal and a fluorescent dye conjugated to the cytosine base. The fluorescent dye is quenched by the interaction with a guanine base. The oligonucleotide is completely complementary to the nucleic acid in the probe-binding region except the one or more cytosine bases present within 1 to 7 bases from the terminal guanine base. The base in the oligonucleotide facing the cytosine base closest to the terminal guanine base among the one or more cytosine bases is a base having no fluorescence-quenching effect.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: September 6, 2022
    Assignee: EIKEN KAGAKU KABUSHIKI KAISHA
    Inventor: Ryohei Saeki